NEURONES (NRO.PA) Stock Cash Flow
EPA:NRO - Euronext Paris - Matif - FR0004050250 - Common Stock - Currency: EUR
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 57.82M | 58.58M | 51.77M | 42.94M | 34.98M | |||
| Depreciation Amortization | 17.70M | 16.76M | 16.57M | 14.68M | 15.97M | |||
| Change In Working Capital | -11.07M | -1.58M | -16.10M | 5.00M | 16.40M | |||
| Taxes Paid | 23.44M | 25.35M | 24.13M | 16.16M | 14.98M | |||
| Other non cash items | -2.28M | -1.68M | 2.72M | 1.88M | -68.00K | |||
| OPERATING CASH FLOW | 62.18M | 72.08M | 54.97M | 64.50M | 67.29M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -19.27M | -17.98M | -10.61M | -6.58M | -7.19M | |||
| Other Investing Activity | -10.40M | -3.59M | -1.65M | -4.04M | -820.00K | |||
| INVESTING CASH FLOW | -29.67M | -21.57M | -12.26M | -10.62M | -8.01M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -3.28M | -3.59M | -7.07M | -6.61M | -6.60M | |||
| Stock Issued/Repurchased | N/A | 57.00K | -107.00K | 89.00K | -1.23M | |||
| Dividend Paid | -29.13M | -26.65M | -24.22M | -48.42M | -4.84M | |||
| Other Financing Activity | 1.49M | 3.12M | -4.67M | -486.00K | 1.62M | |||
| FINANCING CASH FLOW | -30.91M | -27.06M | -36.08M | -55.42M | -11.05M | |||
| Exchange Rate Effect | 41.00K | 34.00K | 252.00K | 130.00K | -174.00K | |||
| CHANGE IN CASH | 1.65M | 23.48M | 6.89M | -1.42M | 48.05M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 62.18M | 72.08M | 54.97M | 64.50M | 67.29M | |||
| Capital Expenditure | -19.27M | -17.98M | -10.61M | -6.58M | -7.19M | |||
| FREE CASH FLOW | 42.91M | 54.09M | 44.36M | 57.92M | 60.10M | |||
All data in EUR